Moderna (NASDAQ: MRNA)stock has rallied by almost 25% since the beginning of this year, currently trading at levels of around $130 per share. There are a couple of developments that are likely driving...
Source LinkNasdaq2021-01-27
Moderna (NASDAQ: MRNA)stock has rallied by almost 25% since the beginning of this year, currently trading at levels of around $130 per share. There are a couple of developments that are likely driving...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Terms and Conditions·Privacy Policy
Company: TTMF Limited. Tech supported by Xiangshang Yixin.
Email:uservice@ttm.financial